Vivos Inc (RDGL)

[wrinklesobw]

I believe almost 3 maybe 4yrs, in that time he has cleaned up the toxic debt/share structure, was able to get the university of Missouri and the vista clinic in Washington on board to do the original isopet testing which I believe they did 3 or 4 pets each and getting the fda to approve it for full animal use.

He has also made several plus patents on the product nationwide and internationally, he redesigned the gel to lower costs and to have complete ownership of the gel so that the company would not have to pay battell to use the gel. They designed a safer way to ship the radiogel, he has also been able to get the Mayo Clinic and the Johns Hopkins vet hospital on board.

In that time there’s been I think at least two additional clinics certified to use isopet which I believe that makes 4 total and in talks with many more locations to come.

There’s major interest starting to form over seas in Europe.

I know I’m missing a lot of other things he has done or is doing currently. But when you put this all done on paper, he’s done a boatload since he’s taken over.

Not going to lie I when the talk of a reverse split came up when he first took over I almost sold, I truly thought that this was just another bs stinky pinky. Then he announced a 8-1 reverse split, there’s not one sub penny play at that time has had that small of a reverse split. So decided to stick around and see what else he could do with this company considering the guy he took over for just about closed the company or at least would have made the share structure even worse that it already was.

So here we are a few years later and we are within months of submitting the ide finally.

So if anyone says the doc has been wasting years on radiogel and is inept is truly wrong. The doctor has accomplished more with a extremely small crew than most companies have with hundreds if not thousands of employees.

So buckle up and let’s see the doctor finish this. Like I said we are mere months away from having this skyrocketing upward.